Free shipping on all orders over $ 500

Chlorotrianisene

Cat. No. M3692

All AbMole products are for research use only, cannot be used for human consumption.

Chlorotrianisene Structure
Synonym:

Chlortrianizen, Chlorotrianisine

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
50mg USD 40  USD40 In stock
100mg USD 70  USD70 In stock
500mg USD 210  USD210 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Chlorotrianisene is a non-steroidal synthetic estrogen that was formerly used for the treatment of menopause, deficiencies in ovary function, and prostate cancer. Chlorotrianisene may react vigorously with strong oxidizing agents. Can react exothermically with reducing agents (such as alkali metals and hydrides) to release gaseous hydrogen. Chlorotrianisene exhibits in vitro little or no binding to the uterine estrogen receptor (ER) but demonstrates potent estrogenic activity in vivo, indicating that Chlorotrianisene is a proestrogen/proantiestrogen. Chlorotrianisene could inhibit bone loss and delay the atrophy of uterus induced by ovariectomy in Wistar female rats. It has protective effects on bone like other estrogen preparations.

Chemical Information
Molecular Weight 380.86
Formula C23H21ClO3
CAS Number 569-57-3
Solubility (25°C) DMSO ≥ 50 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Zhang J, et al. Zhonghua Fu Chan Ke Za Zhi. Prevention of bone loss by chlorotrianisene in oophorectomized rats.

[2] Juedes MJ, et al. Drug Metab Dispos. Monooxygenase-mediated activation of chlorotrianisene (TACE) in covalent binding to rat hepatic microsomal proteins.

[3] Powers CA, et al. Mol Cell Endocrinol. Differential responses of pituitary kallikrein and prolactin to tamoxifen and chlorotrianisene.

[4] Kupfer D, et al. FEBS Lett. Inactivation of the uterine estrogen receptor binding of estradiol during P-450 catalyzed metabolism of chlorotrianisene (TACE). Speculation that TACE antiestrogenic activity involves covalent binding to the estrogen receptor.

Related Estrogen Receptor Products
GDC-0927

GDC-0927 (SRN-927) is a novel, potent, non-steroidal, orally bioavailable, selective estrogen receptor antagonist.

AC-186 

AC-186 is a selective non-steroidal estrogen receptor β (ERβ) agonist with EC50s of 6 nM and 5000 nM for ERβ and ERα, respectively.

Idoxifene

Idoxifene (CB7432) is a novel tissue-specific selective estrogen receptor modulator (SERM).

(R)-Equol

(R)-Equol is an agonist of both ERα and ERβ with Kis of 27.4 and 15.4 nM, respectively.

(Rac)-Vepdegestrant

(Rac)-Vepdegestrant is the isomer of Vepdegestrant.

  Catalog
Abmole Inhibitor Catalog




Keywords: Chlorotrianisene, Chlortrianizen, Chlorotrianisine supplier, Estrogen Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.